Keyphrases
Image-guided
100%
Liver Cancer
100%
Sorafenib
100%
Cancer Immunotherapy
100%
Natural Killer
100%
Adoptive Transfer Immunotherapy
75%
Natural Killer Cells
50%
Tumor Tissue
50%
Antitumor Activity
50%
Transcatheter
50%
Cell-based
50%
Therapeutic Efficacy
50%
Early Adjustment
25%
Serial Monitoring
25%
Homing Efficiency
25%
Concurrent Administration
25%
Non-invasive Device
25%
Tumor Cell Proliferation
25%
Serum Biomarkers
25%
Blood Supply
25%
Clinical Application
25%
Non-responders
25%
Early Biomarker
25%
Tumor
25%
Cell Migration
25%
Cell Trafficking
25%
Liver Tumor
25%
Tumor Size
25%
Targeted Tumor
25%
Inhibit Tumor
25%
Therapy Initiation
25%
Therapeutic Regimen
25%
Delivery Platform
25%
Longitudinal Response
25%
Cytotoxicity
25%
Medicine and Dentistry
Sorafenib
100%
Neoplasm
100%
Liver Cancer
100%
Cancer Immunotherapy
100%
Natural Killer Cell
100%
Adoptive Transfer
75%
Scanning Electron Microscopy
75%
Immunotherapy
75%
Combination Therapy
50%
Biological Marker
50%
Antineoplastic Activity
50%
Infusion
50%
Cell Migration
50%
Cell Proliferation
25%
Tumor Cell
25%
Ex Vivo
25%
Liver Tumor
25%
Vascularity
25%
Side Effect
25%
Cytotoxicity
25%
Microsphere
25%